Stay safe this Monsoon with essential health tips on immunity, hygiene, mosquito control, and diet. Prevent infections and ...

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...

Travelers over 60 advised to seek safer //vaccination alternatives . Individuals aged 60 and above are now being urged not to ...

Sri Laka is currently experiencing a large Chikungunya outbreak after 16 years and the current virus was of the Indian Ocean ...

A study published in The Lancet Planetary Health reveals that tropical mosquito-borne diseases such as dengue and chikungunya ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

CHIKV can trigger long-term joint pain that mimics autoimmune diseases like rheumatoid arthritis, potentially due to ...

The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has been identified in more than 110 countries around the world. The virus typically causes flu-like symptoms, but it can also trigger ...

The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these viruses spread farther north due to global warming, according to new ...

Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved ...

Federal drug safety officials have recommended pausing the use of a vaccine for a mosquito-borne disease known as chikungunya for people over 60 following reports of serious adverse events.